Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in ...

The global hormone-sensitive advanced prostate cancer treatment market is projected to achieve a valuation of USD 12.44 ...

Prostate cancer is Australia's most commonly diagnosed cancer. One in six men will be diagnosed by the time they turn 85.

It’s crucial for patients with prostate cancer to know that all treatments come with side effects, which may affect their ...

When prostate cancer has metastasized, and hormone therapy is no longer effective, or when chemotherapy fails or causes ...

A precursor of vitamin K may help slow down prostate cancer progression, a recent study conducted in mouse models of suggests ...

One thing that's helped for Hartnagel is continuing his dad's legacy with a nonprofit founded in his honor, Metastatic Mission. The organization hosts monthly marathons that take place — just like ...

Urologic oncology researchers in the department of Urology at Hackensack Meridian John Theurer Cancer Center at Hackensack ...

Treatment MarketThe global castration-resistant prostate cancer (CRPC) treatment market is poised for substantial growth, ...

Telix Pharmaceuticals leverages a novel theranostic approach, offering a unique risk-reward model in the challenging biotech ...

How can artificial intelligence (AI) help medical professionals identify, diagnose, and treat prostate cancer? This is what a ...

Sarasota Memorial Research Institute remains committed to advancing medical research and improving patient care through ...